Ra Capital Healthcare Fund Lp - Net Worth and Insider Trading

Ra Capital Healthcare Fund Lp Net Worth

The estimated net worth of Ra Capital Healthcare Fund Lp is at least $3.8 Billion dollars as of 2024-05-11. Ra Capital Healthcare Fund Lp is the 10% Owner of Synthorx Inc and owns about 14,903,741 shares of Synthorx Inc (THOR) stock worth over $1.0 Billion. Ra Capital Healthcare Fund Lp is the Director, 10% Owner of Janux Therapeutics Inc and owns about 9,165,652 shares of Janux Therapeutics Inc (JANX) stock worth over $448 Million. Ra Capital Healthcare Fund Lp is also the 10% Owner of Vaxcyte Inc and owns about 5,001,593 shares of Vaxcyte Inc (PCVX) stock worth over $326 Million. Besides these, Ra Capital Healthcare Fund Lp also holds Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Verastem Inc (VSTM) , Forma Therapeutics Holdings Inc (FMTX) , Rhythm Pharmaceuticals Inc (RYTM) , WAVE Life Sciences Ltd (WVE) , Arvinas Inc (ARVN) , Icosavax Inc (ICVX) , Fulcrum Therapeutics Inc (FULC) , Cytek Biosciences Inc (CTKB) , Achillion Pharmaceuticals Inc (ACHN) , Acumen Pharmaceuticals Inc (ABOS) , Solid Biosciences Inc (SLDB) , DICE Therapeutics Inc (DICE) , G1 Therapeutics Inc (GTHX) , Akouos Inc (AKUS) , Phathom Pharmaceuticals Inc (PHAT) , LENZ Therapeutics Inc (LENZ) , Black Diamond Therapeutics Inc (BDTX) , Imara Inc (IMRA) , Mineralys Therapeutics Inc (MLYS) , Orchard Therapeutics PLC (ORTX) , AN2 Therapeutics Inc (ANTX) , scPharmaceuticals Inc (SCPH) , Therapeutics Acquisition Corp (RACA) , ARS Pharmaceuticals Inc (SPRY) , Tyra Biosciences Inc (TYRA) , Eliem Therapeutics Inc (ELYM) , Elevance Health Inc (ANTX) , Satsuma Pharmaceuticals Inc (STSA) , Nkarta Inc (NKTX) , Acrivon Therapeutics Inc (ACRV) , Vor Biopharma Inc (VOR) , 89bio Inc (ETNB) , PepGen Inc (PEPG) , Boundless Bio Inc (BOLD) , Werewolf Therapeutics Inc (HOWL) , Kala Bio Inc (KALA) . Details can be seen in Ra Capital Healthcare Fund Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ra Capital Healthcare Fund Lp has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).

Transaction Summary of Ra Capital Healthcare Fund Lp

To

Ra Capital Healthcare Fund Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ra Capital Healthcare Fund Lp owns 56 companies in total, including Vaxcyte Inc (PCVX) , 89bio Inc (ETNB) , and Rhythm Pharmaceuticals Inc (RYTM) among others .

Click here to see the complete history of Ra Capital Healthcare Fund Lp’s form 4 insider trades.

Insider Ownership Summary of Ra Capital Healthcare Fund Lp

Ticker Comapny Transaction Date Type of Owner
PCVX Vaxcyte Inc 2020-10-08 10 percent owner
ETNB 89bio Inc 2024-03-04 director & 10 percent owner
RYTM Rhythm Pharmaceuticals Inc 2020-12-03 10 percent owner
2020-06-30 10 percent owner
2020-06-25 10 percent owner
2020-06-23 10 percent owner
2020-05-05 10 percent owner
2020-04-02 director & 10 percent owner
2021-03-11 10 percent owner
2022-12-09 10 percent owner
2022-05-26 director & 10 percent owner
2021-03-15 10 percent owner
2020-01-23 10 percent owner
2021-02-26 director & 10 percent owner
2018-10-23 10 percent owner
2018-10-01 10 percent owner
2018-06-22 10 percent owner
2017-12-18 10 percent owner
2017-05-22 10 percent owner
2016-11-21 10 percent owner
2015-10-22 10 percent owner
2023-12-11 10 percent owner
2014-09-29 other: Former 10% Owner & See FN(5)(6)
2013-06-26 10 percent owner
2014-01-10 other: Fmr 10% Owner - See Fn (1)-(5)
2010-02-26 10 percent owner
2008-10-29 10 percent owner
2008-07-10 10 percent owner
2007-08-08 10 percent owner
2021-08-03 10 percent owner
2023-07-21 director & 10 percent owner
2020-12-07 10 percent owner
2023-03-30 director & 10 percent owner
2020-11-22 10 percent owner
2024-01-11 director & 10 percent owner
2020-09-24 10 percent owner
2021-08-12 director & 10 percent owner
2023-01-06 director & 10 percent owner
2022-03-29 director & 10 percent owner
2024-03-27 10 percent owner
2021-06-29 director & 10 percent owner
2021-04-01 10 percent owner
2021-06-23 director
2021-02-09 director & 10 percent owner
2023-07-19 director & 10 percent owner
2022-03-11 director
2024-02-09 director & 10 percent owner
2021-09-17 director & 10 percent owner
2023-08-18 10 percent owner
2023-01-20 10 percent owner
2022-11-08 director
2022-11-17 director & 10 percent owner
2024-03-27 director
2020-03-11 10 percent owner
2023-02-14 director & 10 percent owner
2023-07-05 director

Ra Capital Healthcare Fund Lp Latest Holdings Summary

Ra Capital Healthcare Fund Lp currently owns a total of 41 stocks. Among these stocks, Ra Capital Healthcare Fund Lp owns 14,903,741 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $1.0 Billion and a weighting of 26.77%. Ra Capital Healthcare Fund Lp owns 9,165,652 shares of Janux Therapeutics Inc (JANX) as of July 19, 2023, with a value of $448 Million and a weighting of 11.85%. Ra Capital Healthcare Fund Lp also owns 5,001,593 shares of Vaxcyte Inc (PCVX) as of October 8, 2020, with a value of $326 Million and a weighting of 8.62%. The other 38 stocks Eidos Therapeutics Inc (EIDX) , Ra Pharmaceuticals Inc (RARX) , Verastem Inc (VSTM) , Forma Therapeutics Holdings Inc (FMTX) , Rhythm Pharmaceuticals Inc (RYTM) , WAVE Life Sciences Ltd (WVE) , Arvinas Inc (ARVN) , Icosavax Inc (ICVX) , Fulcrum Therapeutics Inc (FULC) , Cytek Biosciences Inc (CTKB) , Achillion Pharmaceuticals Inc (ACHN) , Acumen Pharmaceuticals Inc (ABOS) , Solid Biosciences Inc (SLDB) , DICE Therapeutics Inc (DICE) , G1 Therapeutics Inc (GTHX) , Akouos Inc (AKUS) , Phathom Pharmaceuticals Inc (PHAT) , LENZ Therapeutics Inc (LENZ) , Black Diamond Therapeutics Inc (BDTX) , Imara Inc (IMRA) , Mineralys Therapeutics Inc (MLYS) , Orchard Therapeutics PLC (ORTX) , AN2 Therapeutics Inc (ANTX) , scPharmaceuticals Inc (SCPH) , Therapeutics Acquisition Corp (RACA) , ARS Pharmaceuticals Inc (SPRY) , Tyra Biosciences Inc (TYRA) , Eliem Therapeutics Inc (ELYM) , Elevance Health Inc (ANTX) , Satsuma Pharmaceuticals Inc (STSA) , Nkarta Inc (NKTX) , Acrivon Therapeutics Inc (ACRV) , Vor Biopharma Inc (VOR) , 89bio Inc (ETNB) , PepGen Inc (PEPG) , Boundless Bio Inc (BOLD) , Werewolf Therapeutics Inc (HOWL) , Kala Bio Inc (KALA) have a combined weighting of 52.76% among all his current holdings.

Latest Holdings of Ra Capital Healthcare Fund Lp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THOR Synthorx Inc 2018-12-11 14,903,741 67.99 1,013,305,351
JANX Janux Therapeutics Inc 2023-07-19 9,165,652 48.92 448,383,696
PCVX Vaxcyte Inc 2020-10-08 5,001,593 65.19 326,053,848
EIDX Eidos Therapeutics Inc 2018-06-22 2,162,671 122.21 264,300,023
RARX Ra Pharmaceuticals Inc 2018-12-12 4,858,260 47.99 233,147,897
VSTM Verastem Inc 2020-06-25 16,142,051 11.85 191,283,304
FMTX Forma Therapeutics Holdings Inc 2020-06-23 9,011,651 20.01 180,323,137
RYTM Rhythm Pharmaceuticals Inc 2020-12-03 4,360,860 39.14 170,684,060
WVE WAVE Life Sciences Ltd 2023-12-11 19,202,009 5.62 107,915,291
ARVN Arvinas Inc 2018-10-01 3,138,412 31.44 98,671,673
ICVX Icosavax Inc 2022-03-29 5,963,565 15.31 91,302,180
FULC Fulcrum Therapeutics Inc 2023-01-20 11,609,704 7.47 86,724,489
CTKB Cytek Biosciences Inc 2022-03-11 12,797,184 6.30 80,622,259
ACHN Achillion Pharmaceuticals Inc 2013-09-30 11,657,061 6.76 78,801,732
ABOS Acumen Pharmaceuticals Inc 2023-07-21 13,632,029 3.36 45,803,617
SLDB Solid Biosciences Inc 2024-01-11 4,301,877 10.39 44,696,502
DICE DICE Therapeutics Inc 2023-03-30 786,407 47.55 37,393,653
GTHX G1 Therapeutics Inc 2017-05-22 6,691,792 4.77 31,919,848
AKUS Akouos Inc 2020-06-30 2,281,249 13.29 30,317,799
PHAT Phathom Pharmaceuticals Inc 2021-03-11 3,115,008 9.53 29,670,451
LENZ LENZ Therapeutics Inc 2024-03-21 1,389,510 15.73 21,856,992
BDTX Black Diamond Therapeutics Inc 2023-07-05 3,525,754 6.11 21,542,357
IMRA Imara Inc 2022-12-09 3,250,724 6.32 20,544,576
MLYS Mineralys Therapeutics Inc 2023-02-14 1,311,247 13.52 17,728,059
ORTX Orchard Therapeutics PLC 2020-09-24 988,087 16.70 16,501,053
ANTX AN2 Therapeutics Inc 2023-08-18 5,551,295 2.42 13,434,134
SCPH scPharmaceuticals Inc 2021-03-15 2,727,446 4.48 12,218,958
RACA Therapeutics Acquisition Corp 2021-06-29 1,098,318 10.27 11,284,449
SPRY ARS Pharmaceuticals Inc 2024-03-27 902,904 8.74 7,891,381
TYRA Tyra Biosciences Inc 2021-09-17 442,721 17.35 7,681,209
ELYM Eliem Therapeutics Inc 2021-08-12 841,087 8.46 7,115,596
ANTX Elevance Health Inc 2022-03-29 415,612 15.84 6,583,294
STSA Satsuma Pharmaceuticals Inc 2021-02-26 5,155,854 1.10 5,671,439
NKTX Nkarta Inc 2024-03-27 754,311 6.25 4,714,444
ACRV Acrivon Therapeutics Inc 2022-11-17 426,302 8.77 3,738,669
VOR Vor Biopharma Inc 2021-02-09 1,825,326 1.71 3,121,307
ETNB 89bio Inc 2024-03-04 335,364 8.71 2,921,020
PEPG PepGen Inc 2024-02-09 207,672 14.01 2,909,485
BOLD Boundless Bio Inc 2024-04-02 295,844 8.59 2,541,300
HOWL Werewolf Therapeutics Inc 2023-01-06 443,825 5.05 2,241,316
KALA Kala Bio Inc 2022-05-26 140,792 6.90 971,465

Holding Weightings of Ra Capital Healthcare Fund Lp


Ra Capital Healthcare Fund Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 4,545,455 shares on December 11, 2018, which cost Ra Capital Healthcare Fund Lp around $50 Million.

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 1 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Janux Therapeutics Inc is the acquisition of 495,008 shares on July 19, 2023, which cost Ra Capital Healthcare Fund Lp around $6 Million.

According to the SEC Form 4 filings, Ra Capital Healthcare Fund Lp has made a total of 2 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Vaxcyte Inc is the sale of 266,258 shares on October 8, 2020, which brought Ra Capital Healthcare Fund Lp around $14 Million.

More details on Ra Capital Healthcare Fund Lp's insider transactions can be found in the Insider Trading History of Ra Capital Healthcare Fund Lp table.

Insider Trading History of Ra Capital Healthcare Fund Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ra Capital Healthcare Fund Lp Trading Performance

GuruFocus tracks the stock performance after each of Ra Capital Healthcare Fund Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ra Capital Healthcare Fund Lp is 6.08%. GuruFocus also compares Ra Capital Healthcare Fund Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ra Capital Healthcare Fund Lp within 3 months outperforms 34 times out of 73 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ra Capital Healthcare Fund Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ra Capital Healthcare Fund Lp

Average Return

Average return per transaction

Outperforming Transactions

19 out of 58 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.14
Relative Return to S&P 500(%) 6.67

Ra Capital Healthcare Fund Lp Ownership Network

Ownership Network List of Ra Capital Healthcare Fund Lp

No Data

Ownership Network Relation of Ra Capital Healthcare Fund Lp


Ra Capital Healthcare Fund Lp Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Ra Capital Healthcare Fund Lp is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include SVP & Gen Counsel & Corp Sec Mikhail Eydelman , Chief Operating Officer Jim Wassil , and director & President & CEO Grant Pickering .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Ra Capital Healthcare Fund Lp made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 125,936 shares made by Grant Pickering , a net sale of 70,000 shares made by Andrew Guggenhime , and a net sale of 21,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 80,244 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 80,244 shares. During the past 18 months, 273,265 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 273,265 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vaxcyte Inc Insider Transactions

No Available Data

Ra Capital Healthcare Fund Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Ra Capital Healthcare Fund Lp. You might contact Ra Capital Healthcare Fund Lp via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.

Discussions on Ra Capital Healthcare Fund Lp

No discussions yet.